ITGR · Integer Holdings Corp
$96.31
+0.22 (+0.23%)
At close · Jul 21
Market Cap
$3.27B
Shares
33.95M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.85B
+8%
FY2025
Net Income
$102.81M
-14.3%
FY2025
Gross Margin
26.99%
+0.2pp
FY2025
Operating Margin
11.94%
-0.2pp
FY2025
Diluted EPS
$2.89
-14%
FY2025
Operating Cash Flow
$196.15M
-4.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.86B | $1.85B | $1.72B | $1.6B | $1.38B | $1.22B | $1.07B | $1.26B | $1.22B | $1.46B | $1.39B | $800.41M | $687.79M | $663.95M | $646.18M | $568.82M | |
| $1.37B | $1.35B | $1.26B | $1.18B | $1.02B | $884.11M | $787.74M | $903.08M | $852.35M | $1.07B | $1.01B | $565.28M | $456.39M | $444.63M | $444.53M | $388.47M | |
| $489.66M | $500.39M | $459.01M | $418.29M | $359.01M | $336.97M | $285.71M | $355.01M | $362.67M | $393.55M | $378.3M | $235.14M | $231.4M | $219.31M | $201.65M | $180.35M | |
| — | 26.99% | 26.74% | 26.2% | 26.09% | 27.6% | 26.62% | 28.22% | 29.85% | 26.92% | 27.28% | 29.38% | 33.64% | 33.03% | 31.21% | 31.71% | |
| $51.54M | $49.5M | $53.43M | $63.77M | $60.92M | $51.99M | $48.47M | $46.53M | $48.6M | $55.25M | $55M | $53M | $49.85M | $54.08M | $52.49M | $45.51M | |
| $219.3M | $211.75M | $185.2M | $175.62M | $160.58M | $141.42M | $109.01M | $138.7M | $142.44M | $161.57M | $153.29M | $102.53M | $90.6M | $88.11M | $80.99M | $72.55M | |
| $65.49M | $64.35M | $54.61M | $53.17M | $48.31M | $41.6M | $41.13M | $40.08M | $41.46M | $46.71M | $37.86M | $17.5M | $13.88M | $13.17M | $14.26M | — | |
| — | $130.67M | $111.03M | $98.84M | $91.99M | $81.37M | $79.32M | $77.9M | $88.99M | $102.8M | $90.52M | $44.63M | $37.46M | $35.97M | $46.37M | $47.7M | |
| $2.23M | $2.28M | $4.01M | $6.02M | $4.92M | $4.8M | $3.72M | — | — | — | — | — | — | — | — | — | |
| $286.08M | $279.12M | $250.78M | $250.96M | $237.68M | $201.26M | $165.1M | $197.38M | $207.11M | $254.11M | $270.03M | $221.99M | $155.74M | $157.97M | $175.83M | $118.65M | |
| $203.58M | $221.26M | $208.24M | $167.33M | $121.33M | $135.71M | $120.61M | $157.64M | $155.56M | $139.44M | $108.27M | $13.15M | $75.65M | $61.34M | $25.82M | $61.7M | |
| — | 11.94% | 12.13% | 10.48% | 8.82% | 11.11% | 11.24% | 12.53% | 12.8% | 9.54% | 7.81% | 1.64% | 11% | 9.24% | 4% | 10.85% | |
| — | $351.93M | $319.27M | $266.17M | $213.32M | $217.08M | $199.94M | $235.53M | $244.54M | $242.24M | $198.79M | $57.78M | $113.11M | $97.31M | $72.19M | $109.39M | |
| $38.14M | $43.21M | $56.37M | $53.37M | $38.63M | $31.63M | $38.22M | $52.55M | $99.31M | $106.46M | $111.27M | $33.51M | $4.25M | $11.26M | $18.06M | $16.93M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $1000 | $21K | |
| -$5.6M | -$53.21M | -$3.52M | -$975K | $899K | $123K | -$1.52M | $578K | -$752K | -$9.59M | $5.02M | $1.32M | — | — | — | — | |
| -$1.1M | $550K | -$533K | -$481K | -$7.64M | -$3.06M | $5.71M | -$1.1M | -$5.62M | $3.7M | $100K | $4.7M | $1.2M | — | — | — | |
| $158.75M | $125.4M | $147.56M | $107.29M | $75.96M | $101.06M | $86.21M | $105.19M | $61.12M | $21.83M | $1.19M | -$15.7M | $76.58M | $48.84M | $6.73M | $48.39M | |
| $16.95M | $22.57M | $26.51M | $16.64M | $10.61M | $8.04M | $8.95M | $13.98M | $14.08M | -$44.85M | -$4.78M | -$8.11M | $21.12M | $12.57M | $11.53M | $15.27M | |
| $141.8M | $102.81M | $119.9M | $90.65M | $66.38M | $96.81M | $77.26M | $96.34M | $167.96M | $66.68M | $5.96M | -$7.59M | $55.46M | $36.27M | -$4.8M | $33.12M | |
| — | 5.55% | 6.98% | 5.68% | 4.82% | 7.93% | 7.2% | 7.66% | 13.82% | 4.56% | 0.43% | -0.95% | 8.06% | 5.46% | -0.74% | 5.82% | |
| $175.71M | $175.05M | $85.63M | $105.54M | $44.52M | $71.31M | $109.96M | $83.32M | $148.36M | $134.86M | -$11.41M | -$15.35M | $50.22M | $37.68M | -$781K | $31.58M | |
| USD/shares | — | $2.96 | $3.57 | $2.72 | $2.00 | $2.93 | $2.35 | $2.95 | $5.23 | $2.12 | $0.19 | -$0.29 | $2.23 | $1.51 | -$0.20 | $1.42 |
| USD/shares | — | $2.89 | $3.36 | $2.69 | $1.99 | $2.91 | $2.33 | $2.92 | $5.15 | $2.09 | $0.19 | -$0.29 | $2.14 | $1.43 | -$0.20 | $1.40 |
| shares | — | 34.74M | 33.6M | 33.32M | 33.13M | 32.99M | 32.85M | 32.63M | 32.14M | 31.4M | 30.78M | 26.36M | 24.83M | 23.99M | 23.58M | 23.26M |
| shares | — | 35.59M | 35.65M | 33.76M | 33.36M | 33.26M | 33.11M | 33.04M | 32.6M | 31.89M | 30.97M | 26.36M | 25.98M | 25.32M | 23.58M | 23.64M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.43×
Medical Devices median 2.15×
EV/EBIT
22.17×
Medical Devices median 21.36×
P/E (TTM)
23.90×
Medical Devices median 27.72×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $1,853,637,000 | $1,716,596,000 | $1,555,656,000 | — | — | — | — | — |
| Medical Segment | — | — | — | $1,329,551,000 | $1,182,626,000 | $1,037,978,000 | $1,199,679,000 | $1,162,036,000 |
| Non-Medical Segment | — | — | — | $46,545,000 | $38,453,000 | $35,464,000 | $58,415,000 | $52,976,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $979,807,000 | $938,675,000 | $872,926,000 | $732,595,000 | $671,502,000 | $596,804,000 | $698,474,000 | $687,259,000 |
| Rest of World | $469,885,000 | $431,763,000 | $383,730,000 | $408,464,000 | $372,440,000 | $321,737,000 | $341,342,000 | $319,209,000 |
| Costa Rica | $173,524,000 | $124,694,000 | $108,421,000 | $76,140,000 | $66,975,000 | $58,853,000 | $63,634,000 | $62,044,000 |
| Puerto Rico | $131,261,000 | $137,057,000 | $121,487,000 | $114,078,000 | $110,162,000 | $96,048,000 | $154,644,000 | $146,500,000 |
| Ireland | $99,160,000 | $84,407,000 | $69,092,000 | — | — | — | — | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cardio and Vascular | $1,107,084,000 | $949,576,000 | $836,343,000 | $699,401,000 | $593,117,000 | $538,240,000 | $610,056,000 | $585,464,000 |
| Cardiac Rhythm Management Neuromodulation | $668,803,000 | $660,610,000 | $612,891,000 | $534,371,000 | $502,288,000 | $398,409,000 | — | — |
| Other Markets | $77,750,000 | $106,410,000 | $106,422,000 | $97,505,000 | — | — | — | — |
| Advanced Surgical Orthopedics and Portable Medical | — | — | — | — | $87,221,000 | $101,329,000 | $132,429,000 | $133,225,000 |
| Cardiac Neuromodulation | — | — | — | — | $446,569,000 | $346,242,000 | $457,194,000 | $443,347,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $221,264,000 | $208,238,000 | $163,323,000 | $112,678,000 | — | — | — | — |
| Medical Segment | — | — | — | — | $213,600,000 | $169,396,000 | $223,873,000 | $224,893,000 |
| Non-Medical Segment | — | — | — | — | $8,022,000 | $4,848,000 | $16,289,000 | $14,697,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Reportable Segment | 11.9% | 12.1% | 10.5% | — | — | — | — |
| Medical Segment | — | — | — | 18.1% | 16.3% | 18.7% | 19.4% |
| Non-Medical Segment | — | — | — | 20.9% | 13.7% | 27.9% | 27.7% |
Key facts
CIK
1114483
CUSIP
45826H109
13F (30d)
38 filings
38 filers
Visit website
Investor relations